Muslima Ziyoboeva, who would have turned 9 on August 22, died on July 3. She was one of dozens of children who became disabled after taking the Doc-1 Max and Ambronol cold syrups from India's Marion Biotech.
One of the families of the victims reported about Muslima's death. The girl's father, Ilkhom Azimov confirmed the information.
Mass cases of poisoning of children with these drugs occurred from September to December 2022. It was officially reported that 68 children died, and another 23 became disabled.
Muslima was born in 2016 in the Jizzakh province. According to court documents, in December 2022, as prescribed by a doctor, her parents began giving her Doc-1 Max syrup three times a day. The girl's kidneys failed and she could not urinate. She was first taken to a local hospital and then transferred to the National Children's Medical Center in Tashkent. On the way to the capital, Muslima fell into a coma and regained consciousness only a week later.
Despite treatment, the girl was assigned the highest Group I disability. In court in November 2024, her parents said that she could not get up, walk or talk, and the costs of care and treatment were over 10 million soums per month. The total cost at that time was 1 billion soums.
On November 18, 2024, the court recognized five children, including Muslima, as victims and ordered the recovery of 1 billion soums in moral damages from seven defendants, including the former chief of the Pharmaceutical Industry Development Agency, Sardor Kariev. In addition, the court ruled that the 10 thousand dollars seized during the search of his house should be distributed among the legal representatives of the victims - 2000 each.
As the victims said, despite the passing of several months, as of July they had not been paid.
Gulchekhra Murodova, assistant to the judge of the Uchtepa District Criminal Court Dilshod Komilov said that the ruling had not yet taken effect, since in December a number of defendants filed appeals. Among them are Sardor Kariev, his deputies Amirkhon Azimov and Nodirbek Musayev, head of the agency department Shoyusup Shodmonov and the head of the company Quramax Medical (importer of drugs) Raghvendra Pratap Singh.
